Standard Chem & Pharm Co Ltd is a Taiwan-based company principally engaged in the manufacture and sales of western pharmaceuticals, dietary supplement and active pharmaceutical ingredients. The Companyâ€™s products cover circulatory system drugs, digestive system drugs, respiratory system drugs, nervous system drugs, metabolic drugs and general foods and health foods. The Company is also engaged in the sales of medical equipment, animal medicine, cosmetics and milk powder. The Company's products are sold to domestic and overseas markets.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
16/10/26	NT$57.90	0.00%	295,444
15/10/26	NT$57.90	0.00%	246,638
14/10/26	NT$57.90	+1.22%	322,712
13/10/26	NT$57.20	-0.52%	335,427
12/10/26	NT$57.50	+1.05%	615,201

End-of-day quote Taiwan S.E.

More quotes

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Standard Chemical & Pharmaceutical Co., Ltd.

Company calendar

End-of-day quote Taiwan S.E. 16/10/2026			5-day change	1st Jan Change
57.90 ^TWD	0.00%		+1.76%	+8.13%

08-11	Standard Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-13	Standard Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	10.35B 319M 283M 263M 239M 451M 30.27B 458M 3.16B 1.24B 15.79B 1.2B 1.17B 50.35B	P/E 2024	12.6x	P/E 2025	11.4x
Enterprise Value	8.91B 275M 244M 226M 206M 388M 26.06B 395M 2.72B 1.07B 13.6B 1.03B 1.01B 43.36B	EV / Sales 2024	1.45x	EV / Sales 2025	1.29x
Free-Float	44.21%	Yield 2024	4.52%	Yield 2025	3.4%

08-11	Standard Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-13	Standard Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-25	Standard Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-23	Standard Chemical & Pharmaceutical Co., Ltd. announces Annual dividend, payable on August 27, 2026	CI
11-10	Standard Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
05/08/25	Standard Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
12/05/25	Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
03/04/25	Standard Chemical & Pharmaceutical Unit Files for Bankruptcy Over Unpaid Debts	MT
26/03/25	Standard Chemical to Inject NT$99 Million in Easywell Biomedicals	MT
27/02/25	Standard Chemical & Pharmaceutical Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24/02/25	Standard Chemical & Pharmaceutical Co. Ltd. announces Annual dividend, payable on August 28, 2025	CI
16/01/25	Standard Chemical & Pharmaceutical's Dormant Unit Declared Bankrupt	MT
11/11/24	Standard Chemical & Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

02/08/22	Standard Chem & Pharm : Announcement of the company’s board of directors agreeing to lift the prohibition on competition for manager	PU
02/08/22	Standard Chem & Pharm : Announcement of the board approved of the 2022Q2 consolidated financial statements	PU
12/07/22	Standard Chem & Pharm : Announcement of the resolution by the Company’s board of directors for the ex-dividend record date of cash dividends.	PU
21/06/22	Standard Chem & Pharm : Announcement of resolution to release of the Board of Director from non-competition restrictions of the 2022 Annual S.C.P.C. Shareholders’Meeting	PU
21/06/22	Standard Chem & Pharm : Announcement of important resolutions of the 2022 annual Standard Chem. and Pharm. Co., Ltd. shareholders’ Meeting	PU

Standard Chemical & Pharmaceutical Co., Ltd. Share Price

Stocks

1720

TW0001720001

Pharmaceuticals

Valuation: Standard Chemical & Pharmaceutical Co., Ltd.

Chart: Standard Chemical & Pharmaceutical Co., Ltd.

Latest news: Standard Chemical & Pharmaceutical Co., Ltd.

Press Releases: Standard Chemical & Pharmaceutical Co., Ltd.

Quotes and Performance

Price Extremes

Managers and Directors: Standard Chemical & Pharmaceutical Co., Ltd.

Other Pharmaceuticals

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

1 week	+1.76%
Current month	+2.84%
1 month	+3.21%
3 months	+0.30%
6 months	+1.10%
Current year	+8.13%

1 week	56.9	58.3
1 month	55.6	58.3
Current year	53.55	60.55
1 year	49.82	60.55
3 years	46.55	72.18
5 years	34.14	72.36
10 years	24.86	72.36

Manager	Title	Age	Since
Zi Ting Fan CEO	Chief Executive Officer	-	29/05/2006
Reynold Hsu DFI	Director of Finance/CFO	-	15/07/2019
Shu Hua Chen IRC	Investor Relations Contact	-	-

Director	Title	Age	Since
Zi Ting Fan CHM	Chairman	-	-
Yuan Te Li BRD	Director/Board Member	-	05/06/2012
Tsui Wen Yeh BRD	Director/Board Member	-	28/05/2002

	2024	2025
Net sales	6.79B 209M 186M 172M 157M 296M 19.86B 301M 2.07B 813M 10.36B 785M 769M 33.04B	7.02B 216M 192M 178M 162M 306M 20.54B 311M 2.14B 840M 10.72B 812M 795M 34.18B
Net income	881M 27.14M 24.12M 22.36M 20.34M 38.39M 2.58B 39M 269M 105M 1.34B 102M 99.68M 4.28B	928M 28.59M 25.42M 23.56M 21.43M 40.44M 2.71B 41.09M 283M 111M 1.42B 107M 105M 4.51B
Net Debt	-1.24B -38.33M -34.07M -31.58M -28.73M -54.22M -3.64B -55.09M -380M -149M -1.9B -144M -141M -6.05B	-1.44B -44.27M -39.35M -36.47M -33.18M -62.62M -4.2B -63.62M -438M -172M -2.19B -166M -163M -6.99B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STANDARD CHEMICAL & PHARMACEUTICAL CO., LTD.	0.00%	+1.76%	+15.59%	+5.62%	319M
ELI LILLY AND COMPANY	+0.43%	+6.59%	+56.57%	+106.64%	1,120B
JOHNSON & JOHNSON	+0.90%	-2.25%	+32.26%	+63.73%	616B
ABBVIE INC.	+0.71%	+3.24%	+24.33%	+91.33%	504B
ROCHE HOLDING AG	-0.13%	+5.98%	+33.66%	+50.18%	367B
MERCK & CO., INC.	+0.52%	+0.24%	+72.13%	+40.11%	360B
NOVARTIS AG	-0.95%	+4.70%	+19.65%	+42.71%	288B
ASTRAZENECA PLC	-1.98%	+3.73%	-0.89%	+10.43%	258B
AMGEN INC.	-0.35%	+4.25%	+44.74%	+52.06%	234B
GILEAD SCIENCES, INC.	-0.75%	+3.32%	+27.18%	+94.07%	194B
Average	-0.16%	+3.32%	+32.52%	+55.69%	394.12B
Weighted average by Cap.	+0.13%	+3.83%	+39.33%	+71.82%